Irg1 regulates bone homeostasis via regulating the Grk5 expression

Area of Science:

• Biochemistry
• Cell Biology
• Immunology

Background:

• Itaconic acid regulates osteoclast differentiation and impacts osteoporosis.
• The specific role of Irg1 (immune-responsive gene 1) in bone homeostasis is not fully understood.

Purpose of the Study:

• To elucidate the role of Irg1 in bone homeostasis and osteoclast differentiation.
• To investigate the molecular mechanisms underlying Irg1's function in bone cells.

Main Methods:

• Osteoclast differentiation assays using Irg1-deficient bone marrow-derived macrophages (BMMs).
• RNA sequencing (RNA-seq) to analyze gene expression changes.
• In vivo studies using Irg1 knockout mice and micro-CT analysis.
• Assessment of inflammatory factors in bone tissues.

Main Results:

• Irg1 deficiency enhanced osteoclast differentiation and associated gene expression in vitro.
• Irg1 knockout increased Nfatc1 expression and F-actin ring formation, correlating with reduced itaconate production.
• RNA-seq revealed increased Grk5 expression in Irg1-deficient cells; Grk5 inhibition attenuated these effects.
• In vivo studies showed no significant changes in bone structure or osteoclast numbers in Irg1 knockout mice under physiological conditions.
• Elevated inflammatory factors were detected in the bone tissues of Irg1 knockout mice.

Conclusions:

• Irg1 deficiency promotes osteoclastogenesis through the regulation of Grk5 signaling.
• The Irg1-Grk5 axis may represent a therapeutic target for pathological bone conditions.
• Irg1 appears to have a limited role in maintaining bone homeostasis under physiological conditions but influences inflammatory responses.